Renato Skerlj

This inventor holds 33 USPTO granted patents, plus 3 CIPO patents and 6 EPO patents, primarily in Chemokine Receptor Binding. Top assignees: Anormed, Inc., Genzyme Corporation, Merck + Co., Inc.. Active years: 2003-2021.

USPTO Granted Patents = 33

% Patents Active = 57.6

CIPO Patents = 3

EPO Patents = 6 (Patent Applications = 2)

Average Co-Inventor Count = 7.7

ph-index = 17

Forward Citations = 460(Granted Patents)

Location History:

Blaine, WA (US) (2003 - 2005)
Vancouver, CA (2004 - 2011)
Newton, MA (US) (2011)
W. Newton, MA (US) (2021)

Company Filing History:

Years Active: 2003-2021

Loading Chart...

Areas of Expertise:

Chemokine Receptor

Binding Compounds

Heterocyclic Compounds

CXCR4 Antagonist

Antiviral Compounds

Enantiomerically Pure

Amino-Substituted

Fused Bicyclic Rings

Synthesis Methods

Polyamine Compounds

Glucosylceramide Synthase

Chemokine Inhibitors

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11008316 - Glucosylceramide synthase inhibitors (2021-05-18),

2. RE42152 - Aromatic-linked polyamine macrocyclic compounds with anti-HIV activity (2011-02-14),

3. 7863293 - CXCR4 chemokine receptor binding compounds (2011-01-04),

4. 7807694 - Chemokine receptor binding heterocyclic compounds (2010-10-05),

5. 7790747 - Chemokine receptor binding compounds (2010-09-07),

6. 7723525 - Chemokine-binding heterocyclic compound salts, and methods of use thereof (2010-05-25),

7. 7629337 - Chemokine receptor binding heterocyclic compounds (2009-12-08),

8. 7550484 - Chemokine receptor binding heterocyclic compounds with enhanced efficacy (2009-06-23),

9. 7501518 - Methods of making 2,6-diaryl piperidine derivatives (2009-03-10),

10. 7498346 - Chemokine receptor binding compounds (2009-03-03),

11. 7491735 - Chemokine receptor binding compounds (2009-02-17),

12. 7452994 - Synthesis of enantiomerically pure amino-substituted fused bicyclic rings (2008-11-18),

13. 7396840 - Chemokine receptor binding heterocyclic compounds (2008-07-08),

14. 7354934 - Chemokine receptor binding heterocyclic compounds with enhanced efficacy (2008-04-08),

15. 7354932 - Chemokine receptor binding heterocyclic compounds with enhanced efficacy (2008-04-08),

Title: Renato Skerlj: Innovator from Vancouver, CA

Introduction: Renato Skerlj is a renowned inventor based in Vancouver, Canada, known for his groundbreaking contributions to various fields.

Latest Patents: Renato Skerlj holds several patents in the areas of renewable energy technologies, sustainable materials, and innovative healthcare devices.

Career Highlights: With a career spanning over two decades, Renato Skerlj has been instrumental in developing cutting-edge solutions that have significantly impacted industries worldwide. His work has been recognized for its creativity and practicality.

Collaborations: Throughout his career, Renato Skerlj has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work in multidisciplinary teams has led to the successful implementation of numerous projects.

Conclusion: Renato Skerlj's passion for innovation and his dedication to creating solutions for real-world problems make him a standout figure in the world of inventors. His work continues to inspire future generations of innovators.